Flying without a net in MDS

Mikkael A Sekeres

doi:10.1182/blood-2013-09-525444

Back

Journal article

Peer reviewed

Flying without a net in MDS

Mikkael A Sekeres

Blood, Vol.122(17), pp.2925-2926

2013-10-24

DOI: https://doi.org/10.1182/blood-2013-09-525444

PMID: 24159163

Abstract

Antineoplastic Agents - therapeutic use

Hematopoietic Stem Cell Transplantation

Humans

Myelodysplastic Syndromes - diagnosis

Myelodysplastic Syndromes - therapy

In this issue of Blood, Malcovati et al discuss the findings of an expert panel of the European LeukemiaNet (ELN) and their recommendations for treating myelodysplastic syndromes (MDS).

Metrics

5 Record Views

1 Times Cited - Web of Science

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Citation topics: 1 Clinical & Life Sciences; 1.103 Blood Disorders; 1.103.155 Acute Myeloid Leukemia
Web Of Science research areas: Hematology
ESI research areas: Clinical Medicine

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

Source: InCites

Details

Title: Flying without a net in MDS
Creators: Mikkael A Sekeres - Cleveland Clinic
Publication Details: Blood, Vol.122(17), pp.2925-2926
Academic Unit: Miller School of Medicine; UMMG Dept of Medicine - Hematology/Oncology
Language: English
Resource Type: Journal article
PMID: 24159163
Record Identifier: 991031757868502976